Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia

Clinical Lymphoma and Myeloma

Volumn 9, Issue 1, 2009, Pages 100-103

  Menke, Marcel ^a,b   Feke, Gilbert ^a,b   McMeel, J Wallace ^a,b   Treon, Steven ^b,c  

^a Retina Associates Boston   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Immunoglobulin M; Retinal vein; Retinopathy; Serum viscosity; Waldenstr m

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; ARTICLE; BLOOD FLOWMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERVISCOSITY SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; MALE; OPHTHALMOSCOPY; PLASMA VISCOSITY; PLASMAPHERESIS; RETINA BLOOD FLOW; RETINOPATHY; VEIN DIAMETER; VISCOSITY; WALDENSTROEM MACROGLOBULINEMIA; BLOOD; BLOOD VISCOSITY; MIDDLE AGED; PATHOLOGY; RETINA; RETINA DISEASE;

BLOOD VISCOSITY; FEMALE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; OPHTHALMOSCOPY; PLASMAPHERESIS; RETINA; RETINAL DISEASES; WALDENSTROM MACROGLOBULINEMIA;

EID: 67649538151     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.027     Document Type: Article

References (26)

1. Bing J, Neel AV. Two cases of hyperglobulinemia with affection of the central nervous system on a toxi-infectious basis. Acta Medica Scandinavica 1936; LXXXVIII(V-VI):492-506.
2. Wanner J, Siebenmann R. [Subacute osteolytic form of Waldenstrom's macroglobulinemia with plasma cell leukemia.]. Schweiz Med Wochenschr 1957; 87:1243-6.
3. Logothetis J, Silverstein P, Coe J. Neurologic aspects of Waldenstrom's macroglobulinemia; report of a case. Arch Neurol 1960; 3:564-73.
4. Bichel J, Bing J, Harboe N. Another case of hyperglobulinemia and affection of the central nervous system. Acta Med Scand 1950; 138:1-14.
5. Bing J, Fog M, Neel AV. Reports of a third case of hyperglobulinemia with affection of the central nervous system on a toxi-infectious basis, and some remarks on the differential diagnosis. Acta Medica Scandinavica 1937; XCI(IV-V):409-27.
6. Aarseth S, Ofstad E, Torvik A. Macroglobulinaemia Waldenstrom. A case with haemolytic syndrome and involvement of the nervous system. Acta Med Scand 1961; 169:691-9.
7. Dutcher TF, Fahey JL, The histopathology of the macroglobulinemia of Waldenstrom. J Natl Cancer Inst 1959; 22:887-917.
8. Prasad AS, Bloch HS. Macroglobulinemia secondary to a lymphosarcoma of the brain. Arch Intern Med 1960; 105:316-9.
9. Zollinger, H.U., [Pathological anatomy of Waldenstrom's macroglobulinemia.]. Helv Med Acta 1958; 25:153-83.
10. Messaoudene A, Sbai A, Ghillani-Dalbin P, et al. [Waldenstrom macroglobulinemia and involvement of the central nervous system. A case report]. Ann Biol Clin (Paris) 2003; 61:99-102.
11. Edgar R, Dutcher TF. Histopathology of the Bing-Neel syndrome. Neurology 1961; 11:239-45.
12. Garderet L, Baudel JL, Cervera P, et al. 'Indolent' Waldenstrom's macroglobulinemia and a cerebrospinal fluid protein level of 16 g/L. Eur J Haematol 2006; 77:80-2.
13. Monteiro PL, Wildi E. [Waldenstrom's macroglobulinemia with lymphorproliferative changes in the central nervous system. 4 cases]. Schweiz Arch Neurol Neurochir Psychiatr 1975; 116:59-82.
14. Neau JP, Guilhot F, Dumas P, et al. [Central neurologic forms of Waldenstrom's disease. Bing-Neel syndrome. 3 cases]. Rev Neurol (Paris) 1991; 147:56-60.
15. Quilichini, R, Benderitter T, Lafeuillade A, et al. [Waldenstrom's macroglobulinemia with cerebral lymphoproliferative involvement of tumor appearance (Bing and Neel syndrome). An anatomo-clinical case]. Ann Med Interne (Paris) 1989; 140:25-9.
16. Langevin JP, Bergsneider M, Yashar P, et al. Waldenstrom's macroglobulinemia and large B-cell central nervous system lymphoma: a case report. Surg Neurol 2008; 69:407-10.
17. Seitzer B, Spieker C, Schoon ML, et al. [Bing-Neel syndrome. Polyneuropathy within the scope of paraproteinemia]. Fortschr Med 1989; 107:291-3.
18. Vula O, Merhaien P. Cerebral reticuloplasmacytosis with hyperglobulinemia. Its relation to the Bing-Neel syndrome. Eur Neurol 1972; 7:155-68.
19. Fraser, D.M., et al., Mononeuritis multiplex in a patient with macroglobulinaemia. J Neurol Neurosurg Psychiatry 1976; 39:711-5.
20. Arias M, Periero Zabala I, Requena Caballero I, et al. [Rapidly progressing dementia as the presenting symptom of Waldenstrom's macroglobulinemia: findings from magnetic resonance imaging of the brain in Bing Neel syndrome]. Rev Neurol 2004; 38:640-2.
21. Scheithauer BW, Rubinstein LJ, Herman MM. Leukoencephalopathy in Waldenstrom's macroglobulinemia. Immunohistochemical and electron microscopic observations. J Neuropathol Exp Neurol 1984; 43:408-25.
22. Shimizu K, Fujisawa K, Yamamoto H, et al. Importance of central nervous system involvement by neoplastic cells in a patient with Waldenstrom's macroglobulinemia developing neurologic abnormalities. Acta Haematol 1993; 90:206-8.
23. Abad S, Zagdanski AM, Brechignac S, et al. Neurolymphomatosis in Waldenstrom's macroglobulinaemia. Br J Haematol 1999; 106:100-3.
24. Drappatz J, Akar S, Fisher DC, et al. Imaging of Bing-Neel syndrome. Neurology 2008; 70:1364.
25. Rudnicki SA, Harik SI, Dhodapkar M, et al. Nervous system dysfunction in Waldenstrom's macroglobulinemia: response to treatment. Neurology 1998; 51:1210-3.
26. Gunderson CH, Menry J, Malamud N. Plasma globulin determinations in patients with microglioma. Report of five cases. J Neurosurg 1971; 35:406-15.